1173764

Naoto Ueno, M.D. — FEI 3022726116

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 6, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance